Lynn M. Schuchter is a medical oncologist specializing in melanoma and a leading figure in skin cancer research and care. She serves as Director of the Tara Miller Melanoma Center at Penn Medicine, Chief of the Division of Hematology/Oncology at the University of Pennsylvania Perelman School of Medicine, and holds the C. Willard Robinson Professorship in Hematology/Oncology. Dr. Schuchter is the immediate past President of the American Society of Clinical Oncology (ASCO) (2023–2024), where her presidential theme, “The Art and Science of Cancer Care: From Comfort to Cure,” emphasized the integration of scientific innovation with compassionate, patient-centered care.
An internationally recognized leader in melanoma, Dr. Schuchter’s research focuses on immunotherapy, targeted therapies, and mechanisms of treatment resistance, with major contributions to clinical trials that have transformed outcomes for patients with advanced melanoma. She is also a passionate mentor and advocate for women in oncology and received the ASCO Women Who Conquer Cancer Mentorship Award in recognition of her longstanding commitment to developing future leaders in the field.
The 100 Most Influential People in Oncology in 2025 recognizes the changemakers in cancer care who have helped shape current practice in oncology and continue to drive innovation and research towards better outcomes, advocacy, philanthropy, leadership and education. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential People in Oncology in 2025 and stay tuned for the results of special category nominations to be announced.
